The “High Content Screening Market by Instruments (Cell Imaging and Analysis System) by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, andopportunities in North America, Europe, Asia, and the Rest of the World (RoW).
In recent years, the adoption of High Content Screening in various phases of drug discovery has increased. The global was valued at $362.2 million in 2013 and is expected to reach $615.8 million by 2018, at a CAGR of 11.2%. The market is broadly classified based on products, applications, end users, and geographies.
The product market is further divided into instruments, consumables, software, and services. The instruments market is sub-divided into cell imaging and analysis systems and flow cytometers. The consumables market is further segmented into reagents and assay kits, microplates, and other consumables. The software market includes the market for image analysis and data management software. The services market includes screening services such as primary screening and secondary screening, services related to target identification and validation, toxicity studies, and compound profiling.
Get Customized Report: http://www.marketsandmarkets.com/requestCustomization.asp?id=42710391
The applications market includes primary screening and secondary screening, target identification and validation, toxicity studies, compound profiling and other applications. High content screening can be applied in both primary and secondary screening, although it is extensively used for the secondary screening process. In target identification, HCS is used to identify novel targets through the screening of cellular pathways. HCS can also provide more accurate information related to drug toxicity and mode of actions that helps in further decision making and helps to drive the progress of drug discovery. The other application of HCS is in studying cell signaling pathways. The primary and secondary screening market dominated the high content screening applications market, with a market share of 50% in 2013.
The major factors driving the growth of the market include the need for determining the level of toxicity in the early stages of drug discovery pipeline, government support for cell-based research, and the introduction of enhanced informatics solutions and improved image analysis instruments. Moreover, the adoption of HCS for primary screening and its application in the development of personalized medicine are key growth opportunities in this market.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=42710391
The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period, followed by Europe. Over the next five years, the growth of the global market in the Asian region is likely to be centered on China, Japan, Singapore, and India. This growth will be driven by government support for the growth of innovative technologies and the rising demand for outsourcing of drug discovery services.
The major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology (U.S.), Genedata AG (Switzerland), Merck KGaA (Germany), Thorlabs, Inc. (U.S.), and Yokogawa Electric Corporation (Japan), among others
Browse related reports:
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
Optical Imaging Market - Technology Trends and Applications of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) and Photo- Acoustic Tomography (PAT) in Clinical Diagnostics, Clinical Research and Life Sciences With Market Landscape Analysis - (2013-2018)
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets